Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening

Jesper Bonde, Jeppe Bennekou Schroll, Bettina Kjær Kristensen, Elsebeth Lynge, Maria Waldstrøm, Berit Andersen

Abstract

Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.

Bidragets oversatte titelPhased implementation of HPV-based cervical cancer screening in Denmark
OriginalsprogDansk
ArtikelnummerV04210327
TidsskriftUgeskrift for Laeger
Vol/bind184
Udgave nummer9
Sider (fra-til)1-8
Antal sider8
ISSN0041-5782
StatusUdgivet - 28 feb. 2022

Emneord

  • Cervical Intraepithelial Neoplasia
  • Denmark/epidemiology
  • Early Detection of Cancer
  • Female
  • Humans
  • Mass Screening
  • Papillomaviridae
  • Papillomavirus Infections/diagnosis
  • Uterine Cervical Neoplasms/diagnosis
  • Vaginal Smears

Fingeraftryk

Dyk ned i forskningsemnerne om 'Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening'. Sammen danner de et unikt fingeraftryk.

Citationsformater